Previous close | 28.00 |
Open | 28.17 |
Bid | 28.42 x 200 |
Ask | 28.48 x 100 |
Day's range | 27.94 - 28.60 |
52-week range | 13.72 - 33.34 |
Volume | |
Avg. volume | 735,631 |
Market cap | 1.66B |
Beta (5Y monthly) | 2.04 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.39 |
Earnings date | 02 May 2024 - 06 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 44.20 |
The consensus price target hints at a 48.4% upside potential for Protagonist Therapeutics (PTGX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Protagonist Therapeutics, AxoGen, Western Digital and Phunware have been highlighted in this Screen of The Week article.
Celebrations may be in order for Protagonist Therapeutics, Inc. ( NASDAQ:PTGX ) shareholders, with the analysts...